InvestorsHub Logo
Followers 59
Posts 11460
Boards Moderated 0
Alias Born 07/16/2006

Re: Bickema post# 17597

Thursday, 08/17/2017 5:16:48 PM

Thursday, August 17, 2017 5:16:48 PM

Post# of 20689
Bickema,

It seems funny that Mylan, Novartis and Sandoz threw in the towel for 17', yet the ONLY one going to get approved in 2017 remains to be Momenta.


Huh? Somethings wrong with that theory.